SNBL will be exhibiting at the American College of Toxicology from November 17 to 20, 2019. If you are at ACT please pop by Booth and let's chat about how we can support your drug development program.
SNBL and Medgaea Life Sciences, Ltd. (MDG) have signed an agreement for Medgaea Life Sciences to represent SNBL in Taiwan.
The pharmaceutical industry is growing in Taiwan with government support, concentrated around biopharmaceuticals. With its close location and commitment to quality, SNBL is a great choice for preclinical contract research for Taiwanese organizations.
MDG was established in Taiwan in 2005 and offers a variety of preclinical contract research services for medical devices, health foods, pharmaceuticals, and herbal remedies. SNBL and MDG have an excellent cooperative relationship.
The partnership between SNBL and MDG will offer an abundance of support for R&D of pharmaceuticals, medical devices, and regenerative medicine in Taiwan.
At the Safety Pharmacology Society 2019, held in Barcelona from September 23-26, Tsuyoshi Uchino, who is one of SNBL's safety pharmacology experts will present a poster entitled "Utility of Heart Rate Variability Analysis in Telemeterized Cynomolgus Monkeys" on September 24 and 25.
If you are attending SPS, please visit Tsuyoshi at Poster #134.
Otherwise please email email@example.com if you are interested in obtaining a copy of the poster.
SNBL will be exhibiting at the 55th Eurotox Congress from 8 - 11 September in Helsinki, Finland.
Drop by Booth #61 or email firstname.lastname@example.org to see how SNBL can provide preclinical support for your drug development program.
Join SNBL from July 15 to 18 in Honolulu for the 15th International Congress of Toxicology. Drop by Booth 401 or email email@example.com to see how SNBL can provide preclinical support for your drug development program.
SNBL is known for its high quality developmental and reproductive preclinical studies, and we would be happy to discuss how we can help your drug development program at the annual Teratology Society Meeting in San Diego this June. Email firstname.lastname@example.org to make an appointment or visit Booth #4.
Are you attending BIO 2019 in Philadelphia June 3-6? SNBL will be at the JETRO booth #1509, and we would be happy to discuss how our preclinical safety testing can support your drug development program. Email email@example.com to make an appointment.
SNBL will be exhibiting at ARVO, The Association for Research in Vision and Ophthalmology, to be held in Vancouver from April 28 to May 2. We will be at Booth #1643 to introduce our new capability of OCT angiography for preclinical evaluation. Email us at firstname.lastname@example.org to set up a meeting.
One of our pathologists at SNBL, Haruno Yabuki, DVM, received the top honorable mention for a poster she presented at the 35th Scientific Meeting of the Japanese Society of Toxicologic Pathology (JSTP). This meeting is a gathering of nearly all toxicologic pathologists in Japan, whether from pharmaceutical companies or CROs, educational institutions, or public research institutions, and was a great opportunity to show SNBL’s high level of scientific quality.
Congratulations Dr. Yabuki!
For the third year in a row, SNBL Japan received the Health & Productivity Award, presented by the Japanese Ministry of Economy, Trade and Industry. This award recognizes organizations which promote health in their region by implementing strategies to improve the health and productivity of their employees.
As part of its strategy to improve employee health, SNBL Japan has implemented Wellness Tourism seminars, a series of health challenges, and early cancer screenings. SNBL Japan will strive to continue these efforts and ensure that the recognition of our strategy is meaningful.